trial · primary record
Dupilumab coformulated with berahyaluronidase alfa
Healthy Volunteers
| Phase | Phase 1 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 40 |
| Primary completion | 2026-09-30 |
| Primary endpoint | Pharmacokinetic (PK) parameter in serum: Cmax of dupilumab |
| Registry ID | NCT07646548 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:32:37.912Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07646548
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.